Portfolio (Quarterly)
Guide ↗
Foresite Capital Management IV, LLC
· CIK 0001704132| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PHVS | Pharvaris N.V. | Healthcare | 4,778,581.0 | $132.6M | 57.73% | NEW | — | $27.75 | +7.0% |
| 2 | CYTK | CYTOKINETICS INC | Healthcare | 458,295.0 | $29.1M | 12.68% | NEW | — | $63.54 | +21.1% |
| 3 | LYEL | Lyell Immunopharma, Inc. | Healthcare | 800,399.0 | $24.6M | 10.72% | NEW | — | $30.78 | -43.3% |
| 4 | MAZE | Maze Therapeutics, Inc. | Healthcare | 522,657.0 | $21.7M | 9.43% | NEW | — | $41.43 | -37.8% |
| 5 | RLAY | Relay Therapeutics, Inc. | Healthcare | 1,000,000.0 | $8.5M | 3.68% | NEW | — | $8.46 | +59.9% |
| 6 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 160,000.0 | $7.2M | 3.12% | NEW | — | $44.82 | +20.9% |
| 7 | ALEC | Alector, Inc. | Healthcare | 3,887,200.0 | $6.1M | 2.64% | NEW | — | $1.56 | +41.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%